News Daily News Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks Michael O'Riordan August 01, 2025
News Daily News Eye Condition a ‘Very Rare’ Side Effect of Semaglutide, EMA Says Todd Neale June 06, 2025
News Daily News CVD Hospitalization in Older Adults Higher in US Than in Denmark Michael O'Riordan February 07, 2025
News Daily News European Medicines Agency Investigating GLP-1 Drugs and Eye Disease L.A. McKeown January 21, 2025
News Daily News Global Study Shows Sugary Drinks Boosting Diabetes and CVD at Alarming Rates L.A. McKeown January 10, 2025
News Daily News Increased CVD Risk Seen Up to 30 Years Before Type 2 Diabetes Diagnosis Todd Neale November 28, 2024
News Daily News CMS Proposal Would Expand Medicare, Medicaid Coverage for GLP-1 Drugs Todd Neale November 27, 2024
News Daily News No Uptick in Suicidal Thinking With GLP-1 Drugs: Medicare Data Yael L. Maxwell July 15, 2024
News Daily News Even After Multivessel or LM PCI, Routine Stress Testing Adds Nothing Yael L. Maxwell March 01, 2024
News Daily News GLP-1 Receptor Agonists Come With Broad Array of Benefits, Risks Todd Neale January 21, 2024
News Daily News Half of American Indian and Alaska Native Seniors Have CVD: Medicare Analysis L.A. McKeown September 25, 2023
News Daily News New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization Michael O'Riordan July 20, 2023
News Daily News SGLT2i May Be Helpful Early After Acute MI in Diabetic Patients Todd Neale July 17, 2023
News Daily News CVD Claimed 20 Million Lives in 2021, but Disease Burden Varies Globally Michael O'Riordan December 14, 2022
News Daily News Sky-high Cost of SGLT2i and GLP1 Agonists Deter First-line Use L.A. McKeown October 05, 2022
News Daily News Lowering BP Boosts CV Health Irrespective of Diabetes: Meta-analysis Todd Neale August 02, 2022
News Daily News CV Risk Factors, Disease Projected to Explode in Coming Decades L.A. McKeown August 01, 2022
News Daily News Mediterranean Diet Bests Low Fat for Secondary Prevention: CORDIOPREV Michael O'Riordan May 09, 2022